Hansa Biopharma AB (publ) (STO:HNSA)

Hansa Biopharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,497	2,658	1,374	2,581	3,949	10,691
Market Cap Growth	69.72%	93.47%	-46.77%	-34.64%	-63.06%	218.56%
Enterprise Value	4,168	3,064	1,396	2,157	2,963	9,221
Last Close Price	34.36	39.20	26.20	49.22	88.80	240.40
PS Ratio	19.58	15.52	10.25	16.70	116.57	1753.27
PB Ratio	-6.24	-4.51	-8.18	4.28	5.21	8.61
P/TBV Ratio	-	-	-	4.47	5.42	8.83
EV/Sales Ratio	23.34	17.89	10.41	13.96	87.45	1512.21
Debt / Equity Ratio	-1.65	-1.83	-5.16	1.31	0.05	0.00
Asset Turnover	0.21	0.19	0.10	0.11	0.03	0.01
Inventory Turnover	26.30	40.53	50.80	63.34	90.74	-
Quick Ratio	1.10	2.22	2.57	5.91	5.33	12.13
Current Ratio	1.11	2.29	2.66	6.06	5.50	12.20
Return on Equity (ROE)	-	-	-382.37%	-89.84%	-54.84%	-46.63%
Return on Assets (ROA)	-42.29%	-43.41%	-36.55%	-26.67%	-27.56%	-25.32%
Return on Capital (ROIC)	-70.95%	-66.46%	-47.25%	-32.93%	-33.06%	-29.20%
Return on Capital Employed (ROCE)	-177.00%	-115.90%	-113.50%	-40.50%	-64.10%	-32.20%
Earnings Yield	-18.34%	-30.37%	-60.53%	-23.68%	-13.88%	-3.94%
FCF Yield	-	-25.39%	-55.02%	-19.61%	-12.25%	-2.72%
Buyback Yield / Dilution	-23.08%	-19.59%	-16.95%	-1.01%	-5.45%	-5.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.